Psoriasis
Latest News
AAD-NPF releases first guidelines for nonbiologic treatments of psoriasis
Guidelines for nonbiologic systemic agents for psoriasis provide strong evidence for use of apremilast and guidance for off-label drugs.
Case Letter
Human Immunodeficiency Virus Infection in a Hepatitis B Virus–Positive Psoriasis Patient Treated With Ustekinumab
Psoriasis in patients with human immunodeficiency virus (HIV) tends to be more resistant to conventional therapies. Experience is limited in the...
Original Research
Efficacy, Safety, and Tolerability of Halobetasol Propionate 0.01%–Tazarotene 0.045% Lotion for Moderate to Severe Plaque Psoriasis in the Hispanic Population: Post Hoc Analysis
Although psoriasis is a common inflammatory disease, data in the Hispanic population are sparse and disease may be more severe. A recent clinical...
Conference Coverage
Keep your eye on tapinarof, a topical antipsoriatic therapy
LAHAINA, HAWAII – The first-in-class topical aryl hydrocarbon receptor agonist also shows promise for atopic dermatitis.
From the Journals
Specific markers detect psoriatic disease inflammation without elevated CRP
Clinical subsets of psoriatic disease based on organ involvement are characterized by specific inflammation marker profiles in the absence of...
From the Journals
Psoriasis elevates cancer risk
No increased cancer risk occurred in psoriasis patients treated with biologics or in patients with psoriatic arthritis.
From the Journals
Nonspecific musculoskeletal symptoms might indicate early PsA
Diagnosis may be delayed more than 5 years.
From the Journals
Tildrakizumab signals safe for pregnant psoriasis patients
Post hoc analysis of pregnancy outcomes yielded no new concerns for spontaneous abortions or congenital anomalies in women of childbearing age...
Clinical Review
Effect of In-Office Samples on Dermatologists’ Prescribing Habits: A Retrospective Review
There has been growing concern that pharmaceutical interactions and incentives can influence physicians' prescribing habits. This study aimed to...
Clinical Review
Halobetasol Propionate for the Management of Psoriasis
The widespread use of superpotent topical corticosteroids in treating psoriasis is limited by labelling that restricts short-term use, concerns...
Original Research
Adherence to Topical Treatment Can Improve Treatment-Resistant Moderate Psoriasis
Most patients with psoriasis are good candidates for topical treatment. However, psoriasis often is resistant to topical treatment. This study...